Editorial: An unhealthy disregard (subscription)

Major pharmaceutical firms are regularly slapped with huge fines for illegally promoting off-label drug use. But as long as the sales of these drugs dwarf the size of the fines, companies will continue to skirt the law. (Click here to continue reading)

Leave a Reply

Your email address will not be published. Required fields are marked *